Beskrivning:

Southwest Oncology Group Registration Form (S0226) S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer NCT00075764 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3225DE6-8BA0-26CF-E034-0003BA12F5E7

Länk:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3225DE6-8BA0-26CF-E034-0003BA12F5E7
Nyckelord:
  1. 2012-08-26 2012-08-26 -
  2. 2015-04-24 2015-04-24 - Martin Dugas
  3. 2021-09-27 2021-09-27 -
Uppladdad den:

27 september 2021

DOI:
För en begäran logga in.
Licens :
Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Breast Cancer Registration SWOG S0226 NCT00075764

No Instruction available.

  1. StudyEvent: Southwest Oncology Group Registration Form (S0226)
    1. No Instruction available.
Header
Method of Payment
Patient data
Patient Gender
Patient's Ethnicity
Patient's Race
Prior adjuvant tamoxifen therapy
Consent
My tissue may be kept for use in research to learn about, prevent, treat, or cure cancer.
My tissue may be kept for research about other health problems
Someone from Southwest Oncology Group may contact me in the future to ask me to take part in more research
I agree to allow my study doctor, or someone approved by my study doctor, to contact me regard future research involving my participation in this study
I agree to submit blood samples for the purpose of determining how my body metabolizes the drugs, fulvestrant and anastrozole
I agree to submit blood samples for the analysis of human epidermal growth factor receptor 2 (HER-2) protein to see if high levels will predict if I am less likely to respond to hormone therapy
I agree to submit a blood specimen for genetic expression studies to study what role the protocol treatment is having on my disease
I agree to submit a tissue specimen for the analysis of estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER-2) to see if certain levels will predict if I am likely to respond to hormone therapy

Similar models

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial